Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GUSB | P08236 | 2/20 | 0.35 |
| ▸ | EBP | Q15125 | 1/20 | 0.35 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.35 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.33 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.33 |
| ▸ | MGLL | Q99685 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | FAAH | O00519 | 1/20 | 0.33 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.32 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.32 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.32 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.32 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.31 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3209174 | 0.98 | GUSB (0.38) | GUSBEBPSIGMAR1PTGS1PTGS2 | |
| SCHEMBL411403 | 0.98 | GUSB (0.38) | GUSBEBPSIGMAR1PTGS1PTGS2 | |
| SCHEMBL412672 | 0.98 | GUSB (0.38) | GUSBEBPSIGMAR1PTGS1PTGS2 | |
| Hydrochloric Acid SCHEMBL962125 | 0.98 | GNAI3 (0.35) | GUSBEBPSIGMAR1PTGS1PTGS2 | |
| SCHEMBL898380 | 0.98 | GUSB (0.38) | GUSBEBPSIGMAR1PTGS1PTGS2 | |
| SCHEMBL5288773 | 0.98 | GUSB (0.38) | GUSBEBPSIGMAR1PTGS1PTGS2 | |
| SCHEMBL899148 | 0.98 | GUSB (0.38) | GUSBEBPSIGMAR1PTGS1PTGS2 | |
| SCHEMBL409127 | 0.98 | GUSB (0.38) | GUSBEBPSIGMAR1PTGS1PTGS2 | |
| SCHEMBL5289051 | 0.98 | GUSB (0.38) | GUSBEBPSIGMAR1PTGS1PTGS2 | |
| SCHEMBL5291592 | 0.98 | GUSB (0.38) | GUSBEBPSIGMAR1PTGS1PTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 120 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9267214-B2 | Aluminum recovery process | BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) | 2016-02-23 | — | — | US | claimed |
| US-8921589-B2 | Electrolyte formulations | MERCK PATENT GMBH (DE) | 2014-12-30 | — | — | US | claimed |
| US-8829201-B2 | Electrolyte Formulations | MERCK PATENT GMBH (DE) | 2014-09-09 | — | — | US | claimed |
| US-20120318360-A1 | Electrolyte Formulations | MERCK PATENT GMBH (DE) | 2012-12-20 | — | — | US | claimed |
| US-20110000782-A1 | ALUMINUM RECOVERY PROCESS | THE UNIVERSITY OF ALABAMA (US) | 2011-01-06 | — | — | US | claimed |
| US-RE48165-E1 | Alkenyl (perfluoroalkyl) phosphinic acids | MERCK PATENT GMBH (DE) | 2020-08-18 | — | — | US | disclosed |
| WO-2020152206-A1 | LIQUID-CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2020-07-30 | — | — | WO | disclosed |
| CN-107416784-B | Two-dimensional black phosphorus nanosheet and liquid-phase stripping preparation method thereof | 深圳大学 | 2020-05-26 | — | — | CN | disclosed |
| CN-107074890-B | Alkenyl (perfluoroalkyl) phosphinic acids | 默克专利股份公司 | 2019-09-24 | — | — | CN | disclosed |
| US-10160777-B2 | Alkenyl(perfluoroalkyl)phosphinic acids | MERCK PATENT GMBH (DE) | 2018-12-25 | — | — | US | disclosed |
| EP-3207047-B1 | ALKENYL (PERFLUOROALKYL) PHOSPHINIC ACID | MERCK PATENT GMBH (DE) | 2018-09-12 | — | — | EP | disclosed |
| US-20170240574-A1 | ALKENYL (PERFLUOROALKYL) PHOSPHINIC ACIDS | MERCK PATENT GMBH (DE) | 2017-08-24 | — | — | US | disclosed |
| WO-2010069458-A1 | HEXAHALOCHROMATE (LLL) COMPLEXES | MERCK PATENT GMBH (DE) | 2010-06-24 | — | — | WO | disclosed |
| US-20100099031-A1 | NONAQUEOUS ELECTROLYTES AND NONAQUEOUS-ELECTROLYTE SECONDARY BATTERIES EMPLOYING THE SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2010-04-22 | — | — | US | disclosed |
| EP-2166611-A1 | NONAQUEOUS ELECTROLYTE, AND RECHARGEABLE BATTERY WITH THE NONAQUEOUS ELECTROLYTE | Mitsubishi Chemical Corporation (JP) | 2010-03-24 | — | — | EP | disclosed |
| US-20100041916-A1 | PROCESS FOR PRODUCTION OF SULFONIC ACID ESTER | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2010-02-18 | — | — | US | disclosed |
| EP-2067770-A1 | PROCESS FOR PRODUCTION OF SULFONIC ACID ESTER | Wako Pure Chemical Industries, Ltd. (JP) | 2009-06-10 | — | — | EP | disclosed |
| WO-2007006418-A1 | IONIC-LIQUID-CONTAINING PRODUCTS FOR DYEING AND/OR BRIGHTENING KERATIN FIBRES | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2007-01-18 | — | — | WO | disclosed |
| WO-2006131234-A1 | COSMETIC COMPOSITIONS COMPRISING IONIC LIQUIDS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2006-12-14 | — | — | WO | disclosed |
| US-20060186419-A1 | Light-emitting device | KABUSHIKI KAISHA TOSHIBA (JP) | 2006-08-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100041916-A1 | PROCESS FOR PRODUCTION OF SULFONIC ACID ESTER | SULT1A1, SULT2A1, STS | GUSB 2068/4885EBP 990/4885SIGMAR1 348/4885 |
| US-10160777-B2 | Alkenyl(perfluoroalkyl)phosphinic acids | PHOSPHO1, PFAS, SLCO4C1 | GUSB 4197/4885EBP 811/4885SIGMAR1 3607/4885 |
| US-20120318360-A1 | Electrolyte Formulations | NHERF1, HCN4, DDT | GUSB 2077/4885EBP 3813/4885SIGMAR1 4781/4885 |
| US-20170240574-A1 | ALKENYL (PERFLUOROALKYL) PHOSPHINIC ACIDS | PHOSPHO1, PFAS, SLCO4C1 | GUSB 4197/4885EBP 811/4885SIGMAR1 3607/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.